Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-14 Sale | 2024-03-18 6:12 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 318,573 | $5.39 | $1,717,108 | 8,148,305 (Indirect Direct) | View |
2024-03-14 Sale | 2024-03-18 6:02 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 110,804 | $5.39 | $597,234 | 1,031,537 (Direct) | View |
2024-03-14 Sale | 2024-03-18 6:00 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 48,871 | $5.39 | $263,415 | 732,919 (Direct) | View |
2024-03-14 Sale | 2024-03-18 5:57 pm | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer | 28,727 | $5.39 | $154,839 | 308,421 (Direct) | View |
2023-12-01 Purchase | 2023-12-05 7:03 pm | Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director | 30,000 | $2.1789 | $65,367 | 63,000 (Direct) | View |
2023-11-30 Sale | 2023-12-01 7:42 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 3,968 | $1.97 | $7,817 | 6,926,878 (Indirect Direct) | View |
2023-11-30 Sale | 2023-12-01 7:42 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 1,583 | $1.97 | $3,119 | 692,341 (Direct) | View |
2023-11-30 Sale | 2023-12-01 7:42 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 965 | $1.97 | $1,901 | 381,790 (Direct) | View |
2023-11-02 Sale | 2023-11-06 4:56 pm | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Equities No. 7 LLC Alexandria Venture Investments LLC 10% Owner | 247,258 | $2.3142 | $572,204 | 6,359,054 (Indirect) | View |
2023-10-31 Sale | 2023-11-02 4:44 pm | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner | 327,742 | $2.3836 | $781,221 | 6,606,312 (Indirect) | View |
2023-09-27 Sale | 2023-09-29 8:03 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 115,632 | $2.7 | $312,206 | 6,930,846 (Indirect Direct) | View |
2023-09-27 Sale | 2023-09-29 8:02 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 10,932 | $2.7 | $29,516 | 693,924 (Direct) | View |
2023-09-27 Sale | 2023-09-29 8:02 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 9,720 | $2.7 | $26,244 | 382,755 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:34 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 15,870 | $0.91 | $14,442 | 7,046,478 (Indirect Direct) | View |
2023-01-11 Sale | 2023-01-13 4:32 pm | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 6,053 | $0.91 | $5,508 | 704,856 (Direct) | View |
2023-01-11 Sale | 2023-01-13 4:30 pm | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 4,495 | $0.91 | $4,090 | 392,475 (Direct) | View |
2022-10-14 Purchase | 2022-10-14 5:41 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 50,000 | $0.645 | $32,250 | 5,097,986 (Indirect Direct) | View |
2022-10-13 Purchase | 2022-10-13 6:17 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 73,256 | $0.5582 | $40,891 | 5,047,986 (Indirect Direct) | View |
2022-10-12 Purchase | 2022-10-12 8:51 pm | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 38,153 | $0.5227 | $19,943 | 4,974,730 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-12 Option Award | 2024-04-15 5:30 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hooks Corwin Dale Chief Commercial Officer | 300,000 | $0 | 300,000 (Direct) | View |
2023-12-28 Option Award | 2024-03-18 5:51 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Chinoporos Constantine See Remarks | 300,000 | $0 | 300,000 (Direct) | View |
2023-12-21 Option Award | 2023-12-22 8:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,540,000 | $0 | 8,466,878 (Direct) | View |
2023-12-21 Option Award | 2023-12-22 8:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 450,000 | $0 | 1,142,341 (Direct) | View |
2023-12-21 Option Award | 2023-12-22 8:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 400,000 | $0 | 781,790 (Direct) | View |
2023-11-29 Other | 2023-12-01 6:53 pm | N/A N/A | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Equities No. 7 LLC Alexandria Venture Investments LLC 10% Owner | 575,000 | $0 | 1,353,977 (Indirect) | View |
2023-11-20 Option Award | 2023-11-20 4:41 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Chief Financial Officer | 300,000 | $0 | 337,148 (Direct) | View |
2023-10-12 Other | 2023-10-16 7:17 pm | N/A N/A | Applied Therapeutics Inc. | APLT | ALEXANDRIA REAL ESTATE EQUITIES INC. Alexandria Venture Investments LLC Alexandria Equities No. 7 LLC 10% Owner | 2,830,000 | $0 | 5,478,977 (Indirect) | View |
2023-09-15 Exercise | 2023-09-19 8:08 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 12,375 | $0 | 453,414 (Direct) | View |
2023-09-15 Exercise | 2023-09-19 8:08 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 12,375 | $1.05 | 453,414 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:03 pm | N/A N/A | Applied Therapeutics Inc. | APLT | SKYLER JAY S Director | 20,000 | $0 | 20,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:03 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 20,000 | $0 | 441,039 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Lerner Teena Director | 20,000 | $0 | 60,422 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Kanter Stacy J. Director | 20,000 | $0 | 33,000 (Direct) | View |
2023-06-06 Option Award | 2023-06-08 9:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Funtleyder Leslie D. Director | 20,000 | $0 | 37,148 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:34 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Shendelman Shoshana President and CEO 10% Owner | 1,964,362 | $0 | 7,046,478 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:32 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Perfetti Riccardo Chief Medical Officer | 550,000 | $0 | 704,856 (Direct) | View |
2023-01-11 Option Award | 2023-01-13 4:30 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Hansard Adam Chief Commercial Officer | 300,000 | $0 | 392,475 (Direct) | View |
2022-11-15 Option Award | 2022-11-17 9:31 pm | N/A N/A | Applied Therapeutics Inc. | APLT | Ortega Steven A. Principal Accounting Officer | 40,000 | $0 | 55,404 (Direct) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A 2029-05-12 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 13,071 | $0 | 74,824 (Direct) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 35,911 | $4.7 | 74,824 (Indirect) | View |
2021-04-14 Exercise(A) | 2022-09-16 9:02 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 13,071 | $10 | 74,824 (Indirect) | View |
2022-09-14 Exercise | 2022-09-16 9:01 pm | N/A 2029-05-12 | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 38,244 | $0 | 433,414 (Direct) | View |
2022-09-14 Exercise | 2022-09-16 9:01 pm | N/A N/A | Applied Therapeutics Inc. | APLT | MARCUS JOEL S Director | 38,244 | $1.05 | 433,414 (Direct) | View |
2022-08-02 Disposition | 2022-08-04 8:41 pm | N/A 2032-06-02 | Applied Therapeutics Inc. | APLT | SKYLER JAY S Director | 127,380 | $0 | 63,690 (Direct) | View |